Botulinum toxin type A: Exploring new indications

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations


The use of botulinum toxin has expanded in the last five years to include traditional neurological use against dystonia and spasticity, as well as the emerging use for headache, pain, neuropathy, myofascial pain, joint arthritis, otolaryngology, gastroenterology and genitourinary disorders. This review will focus on these emerging uses of botulinum toxin as reported in recent literature. The exploratory use of botulinum toxin for cervical dystonia, blepharospasm and spasticity in small trials and case reports, has led to its detailed study in larger placebo-controlled clinical trials. Although the use of botulinum toxin for new indications may benefit a specific subset of patients with refractory pain and disability, the reader must realize that this is an emerging area, generally limited by a lack of large, placebo-controlled studies.

Original languageEnglish (US)
Pages (from-to)671-682
Number of pages12
JournalDrugs of Today
Issue number9
StatePublished - Sep 1 2010
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Botulinum toxin type A: Exploring new indications'. Together they form a unique fingerprint.

Cite this